When your patients and protocols require a targeted assay or specialist methodology, we offer a range of assays to meet your needs. If non-standard tests are required, CentraLabS scientists are experienced and expert in developing and validating novel assays.

Clinical Immunology

• Flow cytometry (FACS)
• Leukocyte immunophenotyping panels
• NK cell activity
• Mitogen and recall antigen assays
• Assay development/transfer appropriate to drug pharmacology

Peripheral Blood Mononuclear Cells (PBMC) preparations

We have global protocols that deliver consistent cell preparations for a variety of therapeutic areas including;

• HIV 1&2, Hep B & HCV vaccine studies
• Cytokine and immunology studies
• Inflammation response markers

Specialist Therapeutic Assay Panels

• Bone marker assays
• Insulin replacement therapy panels; glucagon, C-peptide, GIP, GLP1
• Thrombosis & circulation disorders; VCAM, ICAM, PEGF
• Oncology tumour markers; CA-19-9, CEA, H-Pylori, gastrin
• Chromagenic coagulation assays
• Ultra-sensitive fibrinogen assay, D-Dimer, FDP's
• Urinary markers of kidney damage; alpha-GST, B2-microglobulin
• Iso-enzyme electrophoresis
• Specialist hematology panel; iron status, STfr, reticulocyte maturation indices

Pediatric Studies

CentraLabS understands the needs of this hugely important and emerging clinical field. Unlike other central laboratories we offer customised sample collection kits, which allow reduced blood volumes to be drawn. In addition, our laboratory instruments have the reduced sample mode that ensures that a 18 parameter chemistry panel can be analysed from as little as 600 micro-Litres of plasma. This approach ensures that both patient safety data and ethics requirements are accommodated.